17 July 2025
FD Technologies plc
PDMR Notice and Issue of Equity
FD Technologies plc (the "company") (AIM: FDP.L, Euronext Growth: FDP.I) announces that on 17 July 2025 the Company allotted 1,059,184 new ordinary shares of £0.005 each in the Company ("the Ordinary Shares") following the vesting of awards granted under the Company's long term incentive plan and the exercise of options granted under the Company's unapproved employee share scheme.
Application has been made for the new Ordinary Shares to be admitted to trading on AIM and Euronext Growth and it is expected that admission will take place on 18 July 2025. The new Ordinary Shares will rank pari passu with the existing shares of the Company. Following these allotments, the total issued share capital of the Company will increase to 23,256,424 ordinary shares.
Enquiries
For further information please contact:
|
FD Technologies plc Derek Brown, Head of Investor Relations
|
+44(0)28 3025 2242 |
|
|
|
|
|
|
Investec Bank plc (Nominated Adviser and Broker) Carlton Nelson Virginia Bull |
+44 (0) 20 7597 5970 |
|
|
|
|
|
|
FTI Consulting LLP (Financial PR) Matt Dixon Dwight Burden Victoria Caton |
+44 (0) 20 3727 1000 FDtechnologies@fticonsulting.com |
|
About KX
KX is on a mission to make AI a commercial reality for the many by addressing data challenges that impede deployment at scale. By simultaneously ingesting and analysing high volumes of historical and real-time data, KX's AI-ready analytical database enables organizations to unlock the full value of their data to accelerate innovation and make faster, more confident decisions.
KX is the world's most performant, cost-effective and energy-efficient analytical database, delivering advanced data algorithms, insights and analytics at unmatched scale and speed. KX is trusted by the world's top investment banks, Aerospace and Defence, high-tech manufacturing and health and life sciences organizations and operates across North America, Europe, and Asia Pacific.
For further information, please visit www.fdtechnologies.com
For further information, please visit www.fdtechnologies.com and www.kx.com
|
1. |
Details of PDMR / person closely associated with them ("PCA") |
|||||||||||||||||||||||||
|
a)
|
Names
|
Seamus Keating, Ryan Preston and Ashok Reddy |
||||||||||||||||||||||||
|
2. |
Reason for the notification |
|||||||||||||||||||||||||
|
a) |
Position / status |
Seamus Keating - Chief Executive Officer of FD Technologies Ryan Preston - Chief Financial Officer of FD Technologies Ashok Reddy - Chief Executive Officer of KX
|
||||||||||||||||||||||||
|
b) |
Initial notification / amendment |
Initial Notification |
||||||||||||||||||||||||
|
3. |
Details of the Issuer |
|||||||||||||||||||||||||
|
a) |
Name |
FD Technologies plc |
||||||||||||||||||||||||
|
b) |
LEI |
213800MKQAJ5R7WIU633 |
||||||||||||||||||||||||
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||||||||||||||||||||
|
a) |
Description of the financial instrument, type of instrument |
Ordinary Shares of £0.005 ISIN: GB0031477770 |
||||||||||||||||||||||||
|
b) |
Nature of the transaction |
Shares acquired following the vesting of awards under the Company's long term incentive plan and the exercise of options granted under the Company's unapproved employee share scheme. |
||||||||||||||||||||||||
|
c) |
Price(s) and volume(s) |
Seamus Keating
Ryan Preston
Ashok Reddy
|
||||||||||||||||||||||||
|
d) |
Aggregated information - Aggregated volume
- Price |
Seamus Keating:143,514 Ryan Preston: 68,270 Ashok Reddy: 258,093
Seamus Keating: £0.005 Ryan Preston: £9.824 Ashok Reddy: £14.271
|
||||||||||||||||||||||||
|
e) |
Date of the transaction |
17 July 2025 |
||||||||||||||||||||||||
|
f) |
Place of the transaction |
London Stock Exchange (XLON) |
||||||||||||||||||||||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
